These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17032344)

  • 1. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
    Stoiser B; Mörtl D; Hülsmann M; Berger R; Struck J; Morgenthaler NG; Bergmann A; Pacher R
    Eur J Clin Invest; 2006 Nov; 36(11):771-8. PubMed ID: 17032344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.
    Miller WL; Grill DE; Struck J; Jaffe AS
    Am J Cardiol; 2013 Mar; 111(6):880-5. PubMed ID: 23276468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
    Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
    Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
    Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
    J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and renal function influence plasma levels of copeptin in healthy individuals.
    Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
    Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is B-type natriuretic peptide-guided heart failure management cost-effective?
    Morimoto T; Hayashino Y; Shimbo T; Izumi T; Fukui T
    Int J Cardiol; 2004 Aug; 96(2):177-81. PubMed ID: 15262031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.
    Knudsen CW; Clopton P; Westheim A; Klemsdal TO; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel AS; Omland T
    Ann Emerg Med; 2005 Jun; 45(6):573-80. PubMed ID: 15940086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients.
    Christ M; Sharkova Y; Fenske H; Rostig S; Herzum I; Becker HF; Mueller C; Grimm W
    Int J Cardiol; 2007 Mar; 116(1):62-9. PubMed ID: 16820230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
    Berger R; Huelsmann M; Strecker K; Moertl D; Moser P; Bojic A; Pacher R
    Eur J Clin Invest; 2005 Jan; 35(1):24-31. PubMed ID: 15638816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.